Clinical Trial Update: Invaplex 50 Vaccine Dose-Ranging [Phase 1]

View source ↗

Summary

The update reports the completion of a Phase 1 dose-ranging study of the Invaplex 50 vaccine evaluated for diarrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Invaplex 50 (Invaplex 50)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Diarrhea | Phase 1 | Status: COMPLETED